Economic burden of diabetes in Brazil in 2014

Página do item simplificado
dc.contributor.authorBahia, Luciana Ribeiro
dc.contributor.authorRosa, Michelle Quarti Machado da
dc.contributor.authorAraujo, Denizar Vianna
dc.contributor.authorCorreia, Marcelo Goulart
dc.contributor.authorRosa, Roger dos Santos dos
dc.contributor.authorDuncan, Bruce Bartholow
dc.contributor.authorToscano, Cristiana Maria
dc.date.accessioned2024-10-10T18:22:36Z
dc.date.available2024-10-10T18:22:36Z
dc.date.issued2019
dc.description.abstractBackground: Diabetes and its complications produce signifcant clinical, economic and social impact. The knowl- edge of the costs of diabetes generates subsidies to maintain the fnancial sustainability of public health and social security systems, guiding research and health care priorities. Aims: The aim of this study was to estimate the economic burden of diabetes in Brazilian adults in 2014, considering the perspectives of the public health care system and the society. Methods: A prevalence-based approach was used to estimate the annual health resource utilization and costs attributable to diabetes and related conditions. The healthcare system perspective considered direct medical costs related to outpatient and hospitalization costs. The societal perspective considered non-medical (transportation and dietary products) and indirect costs (productivity loss, disability, and premature retirement). Outpatient costs included medicines, health professional visits, exams, home glucose monitoring, ophthalmic procedures, and costs related to end stage renal disease. The costs of hospitalization attributed to diabetes related conditions were estimated using attributable risk methodology. Costs were estimated in Brazilian currency, and then converted to international dollars (2014). Results: Based on a national self-reported prevalence of 6.2%, the total cost of diabetes in 2014 was Int$ 15.67 billion, including Int$ 6.89 billion in direct medical costs (44%), Int$ 3.69 billion in non-medical costs (23.6%) and Int$ 5.07 billion in indirect costs (32.4%). Outpatient costs summed Int$ 6.62 billion and the costs of 314,334 hospitalizations attributed to diabetes and related conditions was Int$ 264.9 million. Most hospitalizations were due to cardiovascu- lar diseases (47.9%), followed by diabetes itself (18%), and renal diseases (13.6%). Diet and transportation costs were estimated at Int$ 3.2 billion and Int$ 462.3 million, respectively. Conclusions: Our results showed a substantial economic burden of diabetes in Brazil, and most likely are underrated as they are based on an underestimated prevalence of diabetes. Healthcare policies aiming at diabetes prevention and control are urgently sought.
dc.identifier.citationBahia LR, da Rosa MQM, Araujo DV, Correia MG, Dos Rosa RDS, Duncan BB, Toscano CM. Economic burden of diabetes in Brazil in 2014. Diabetol Metab Syndr. 2019 Jul 2;11:54. doi: 10.1186/s13098-019-0448-4.
dc.identifier.otherDOI: 10.1186/s13098-019-0448-4
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/485
dc.language.isoen
dc.publisherDiabetology & Metabolic Syndrome
dc.subjectType 2 diabetesen
dc.subjectCost analysisen
dc.subjectCost studiesen
dc.subjectPublic healthen
dc.titleEconomic burden of diabetes in Brazil in 2014
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Bahia LR et al_Diabetology & Metabolic Syndrome.pdf
Tamanho:
632.89 KB
Formato:
Adobe Portable Document Format
Descrição:
Baixar
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar
Coleções
Produção Docente